F
F. Sarrot-Reynauld
Researcher at Centre Hospitalier Universitaire de Grenoble
Publications - 3
Citations - 540
F. Sarrot-Reynauld is an academic researcher from Centre Hospitalier Universitaire de Grenoble. The author has contributed to research in topics: Randomized controlled trial & Hematopoietic stem cell transplantation. The author has an hindex of 2, co-authored 3 publications receiving 449 citations.
Papers
More filters
Journal ArticleDOI
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial
J.M. van Laar,Dominique Farge,Jacob K. Sont,Kamran Naraghi,Zora Marjanovic,Jérôme Larghero,Annemie J. Schuerwegh,Erik W.A. Marijt,Madelon C. Vonk,Anton Schattenberg,Marco Matucci-Cerinic,A E Voskuyl,A.A. van de Loosdrecht,Thomas Daikeler,Ina Kötter,Marc Schmalzing,Thierry Martin,Bruno Lioure,S.M. Weiner,Alexander Kreuter,Christophe Deligny,Jean-Marc Durand,Paul Emery,Klaus P Machold,F. Sarrot-Reynauld,Klaus Warnatz,Daniel Adoue,Joël Constans,Hans-Peter Tony,N. Del Papa,A Fassas,Andrea Himsel,David Launay,A. Lo Monaco,P. Philippe,Isabelle Quéré,E. Rich,Rene Westhovens,Bridget Griffiths,Riccardo Saccardi,F.H.J. van den Hoogen,Willem E. Fibbe,Gérard Socié,Alois Gratwohl,Alan Tyndall +44 more
TL;DR: Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment, however, HCST conferred a significant long-term event-free survival benefit.
Journal ArticleDOI
Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques pour le traitement des maladies auto-immunes
Zora Marjanovic,I. Gerber,Cecile Toledano,J. hen-Solal,R. Damade,I. de Saint-Cyr,F. Sarrot-Reynauld,D. Ilie,M. Daneshpouy,Nicolas Mounier,Marc Ruivard,C. Tyndall,Elisabeth Vidal,Isabelle Quéré,Jean-Marc Durand,Joël Constans,Dominique Farge +16 more
TL;DR: Pour ameliorer l’efficacite et the securite de ce traitement intensif chez des patients dont les organes vitaux sont affectes par the maladie auto-immune sous-jacente, il est important of suivre les recommandations du consensus international.
Journal ArticleDOI
Suivi à long terme des patients traités par autogreffe de moelle pour maladie autoimmune sévère
Dominique Farge-Bancel,Zora Marjanovic,S. Hadj Khelifa,Annalisa Ruggeri,Thierry Martin,Christophe Deligny,J.-M. Duran,F. Sarrot-Reynauld,D. Adoue,J. Constans,P. Philippe,John A. Snowden +11 more